Hemofília: vizsgálatok itt: Spanyolország
32 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
- Where
- Esplugues de Llobregat, Madrid, Málaga
- Életkor
- 2 év to 59 év
- People
- 60 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05987449 · EU 2023-503906-35-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Where
- Barcelona, Madrid, Málaga, Sevilla, Valencia
- Életkor
- 12 év and over
- People
- 360 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416604 · EU 2025-522435-33-00 - 3. fázisTaking peopleA Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
- Where
- Barcelona, Madrid, Murcia, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07830732 · EU 2026-525529-19-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
- Where
- Esplugues de Llobregat, Madrid, Zaragoza
- Életkor
- 1 év to 11 év
- People
- 85 worldwide
- Run by
- Sanofi
See details and how to joinNCT07285460 · EU 2025-521858-42-00 - 3. fázisTaking peopleOpen-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Where
- A Coruña, Barcelona, Madrid, Zaragoza
- Életkor
- 1 év to 74 év
- People
- 245 worldwide
- Run by
- Pfizer
See details and how to joinNCT05145127 · EU 2022-500470-33-00 - No phaseTaking peopleAn Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A
- Where
- Many Locations
- Életkor
- 7 év to 12 év
- People
- 40 worldwide
- Run by
- Bayer
See details and how to joinNCT07088458 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
- Where
- Barcelona, Madrid, Málaga, Sevilla, Valencia
- Életkor
- 12 év and over
- People
- 138 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416526 · EU 2025-522434-32-00 - 3. fázisTaking peopleA Non-Investigational Product, Multi-Center Cohort Study to Describe Long-Term Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec
- Where
- El Palmar, Murcia, Valladolid
- Életkor
- 18 év to 64 év
- People
- 32 worldwide
- Run by
- Pfizer Inc.
See details and how to join2025-523660-21-00 · EU 2025-523660-21-00 - 1/2. fázisTaking peopleA Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
- Where
- A Coruña, Barcelona, Madrid, Murcia, Oviedo, Sevilla, Valencia, Zaragoza
- Életkor
- 2 év and over
- People
- 130 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06379789 · EU 2023-507260-40-00 - 3. fázisTaking peoplePhase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
- Where
- Esplugues de Llobregat, Madrid
- Életkor
- 138 hónap to 206 hónap
- People
- 20 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07080905 · EU 2023-505805-18-00 - 3. fázisTaking peopleA Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
- Where
- Madrid, Zaragoza
- Életkor
- 1 év to 17 év
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05611801 · EU 2022-500495-65-00 - 3. fázisTaking peopleSafety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Where
- Valladolid
- Életkor
- 18 év and over
- People
- 173 worldwide
- Run by
- Pfizer
See details and how to joinNCT05568719 - No phaseNot yet taking people in SpanyolországMulticomponent Pain Self-Management in Adults With Haemophilic Arthropathy
- Where
- Madrid
- Életkor
- 18 év and over
- People
- 70
- Run by
- Investigación en Hemofilia y Fisioterapia
See details and how to joinNCT07860632 - 4. fázisTaking peopleTreatment of Hemophilia A Patients With FVIII Inhibitors
- Where
- Alicante, Barcelona, Sant Joan d'Alacant, Sevilla
- People
- 120 worldwide
- Run by
- Emory University
See details and how to joinNCT04023019 · EU 2024-516741-39-00 - 4. fázisTaking peopleA Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
- Where
- A Coruña, Madrid, Zaragoza
- Életkor
- 12 év and over
- People
- 20 worldwide
- Run by
- Sanofi
See details and how to joinNCT06145373 · EU 2022-502414-84-00 - 1. fázisTaking peopleA Phase Ib Safety, Pharmacokinetics and Pharmacodynamics Study of TU7710 in Patients with Haemophilia A or B
- Where
- Málaga, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 21 worldwide
- Run by
- Tiumbio Co. Ltd.
See details and how to join2024-511814-20-00 · EU 2024-511814-20-00 - 1. fázisTaking peopleA Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
- Where
- Barcelona, Madrid, Málaga, Salamanca, Valencia
- Életkor
- 18 év to 64 év
- People
- 30 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07220564 · EU 2025-520490-38-00 - 4. fázisTaking peopleNuwiq Dosing and outcomes In the ManagEment of women/girls with haemophilia A Needing FVIII treatment for Surgery – an International, Open-label, Non-controlled study (NuDIMENSION)
- Where
- Madrid, Sevilla
- People
- 17 worldwide
- Run by
- Octapharma AG
See details and how to join2022-502061-17-00 · EU 2022-502061-17-00 - No phaseTaking peopleEfficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- Where
- Alicante, Barcelona, Málaga, Palma de Mallorca, Valencia
- People
- 200 worldwide
- Run by
- Octapharma
See details and how to joinNCT03695978 - 4. fázisTaking peopleNuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
- Where
- Madrid, Seville
- Életkor
- 12 év and over
- People
- 28 worldwide
- Run by
- Octapharma
See details and how to joinNCT05935358 - 4. fázisTaking peopleNuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
- Where
- Madrid, Seville
- Életkor
- 12 év and over
- People
- 28 worldwide
- Run by
- Octapharma
See details and how to joinNCT05936580 - No phaseNot yet taking people in SpanyolországIncidence of Ultrasonographically Detected Articular Damage in Initially Healthy Joints of Patients With Hemophilia A Receiving Prophylactic Treatment With Emicizumab
- Where
- Oviedo
- Életkor
- 10 év and over
- People
- 70
- Run by
- Investigación en Hemofilia y Fisioterapia
See details and how to joinNCT07420348 - No phaseNot yet taking people in SpanyolországEffectiveness of an Educational Program for Pain Management in Patients With Hemophilic Arthropathy
- Where
- Oviedo
- Életkor
- 18 év and over
- People
- 70
- Run by
- Investigación en Hemofilia y Fisioterapia
See details and how to joinNCT07420387 - No phaseTaking peopleAn Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
- Where
- Vigo
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- CSL Behring
See details and how to joinNCT06008938 - 4. fázisCsak meghívásosA Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
- Where
- A Coruña, Sevilla
- Életkor
- 18 év and over
- People
- 172 worldwide
- Run by
- BioMarin Pharmaceutical
See details and how to joinNCT05768386 · EU 2023-507749-27-00